CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in AdultsFrancesco Lanza, Fabio Malavasi, Evita Massari et al.|Cancers|2020Cited by 78
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma ModelBeatrice Anna Zannetti, Francesco Lanza, Angelo Corso Faini et al.|Cells|2020Cited by 20
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemiaFrancesco Lanza, Giovanni Martinelli, Enrico Maffini et al.|Minerva Medica|2020Cited by 4